These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4302157)

  • 21. Combined live measles-mumps virus vaccine.
    Weibel RE; Villarejos VM; Hernández G; Stokes J; Buynak EB; Hilleman MR
    Arch Dis Child; 1973 Jul; 48(7):532-6. PubMed ID: 4719108
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella.
    Nasibov MN; Yakovleva NV; Smorodintsev AA
    Prog Immunobiol Stand; 1970; 4():676-82. PubMed ID: 5482205
    [No Abstract]   [Full Text] [Related]  

  • 23. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study of simultaneous measles and mumps immunization].
    Cernescu C; Strulovici D; Cepleanu M; Sorodoc Y; Copelovici Y
    Stud Cercet Virusol; 1973; 24(5):363-8. PubMed ID: 4747455
    [No Abstract]   [Full Text] [Related]  

  • 25. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles and mumps immunization: benefit versus risk factors.
    Krugman S
    Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland.
    Peltola H; Karanko V; Kurki T; Hukkanen V; Virtanen M; Penttinen K; Nissinen M; Heinonen OP
    Lancet; 1986 Jan; 1(8473):137-9. PubMed ID: 2867355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
    Stokes J; Weibel RE; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 Oct; 218(1):57-61. PubMed ID: 4937795
    [No Abstract]   [Full Text] [Related]  

  • 31. Simultaneous administration of live virus vaccines. Measles, mumps, poliomyelitis, and smallpox.
    Karchmer AW; Friedman JP; Casey HL; Shope TC; Riker JB; Kappelman MM; Witte JJ
    Am J Dis Child; 1971 May; 121(5):382-8. PubMed ID: 4933290
    [No Abstract]   [Full Text] [Related]  

  • 32. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures.
    Fescharek R; Quast U; Maass G; Merkle W; Schwarz S
    Vaccine; 1990 Aug; 8(4):333-6. PubMed ID: 2396472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases.
    Vaccine; 1998 May; 16(8):818-22. PubMed ID: 9627939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined live measles, mumps, rubella vaccine. Immunological response.
    Krugman S; Muriel G; Fontana VJ
    Am J Dis Child; 1971 May; 121(5):380-1. PubMed ID: 5091532
    [No Abstract]   [Full Text] [Related]  

  • 35. A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile.
    Borgoño JM; Greiber R; Solari G; Concha F; Carrillo B; Hilleman MR
    Clin Pediatr (Phila); 1973 Mar; 12(3):170-2. PubMed ID: 4701464
    [No Abstract]   [Full Text] [Related]  

  • 36. Live, attenuated mumps-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
    [No Abstract]   [Full Text] [Related]  

  • 37. A benefit-cost analysis of two-dose measles immunization in Canada.
    Pelletier L; Chung P; Duclos P; Manga P; Scott J
    Vaccine; 1998; 16(9-10):989-96. PubMed ID: 9682349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization].
    Rodríguez Borrego MJ; García León J; Bolumar F; Nájera E
    Rev Sanid Hig Publica (Madr); 1985; 59(1-2):117-25. PubMed ID: 4059834
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [1st results with a combined live vaccine against measles, mumps, and rubella].
    Stehr K; Epp C; Spiess H
    Monatsschr Kinderheilkd (1902); 1975 May; 123(5):410-2. PubMed ID: 1219453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.